 | • レポートコード：MRC2301G082 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、253ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：消費財 |
| Single User（1名利用、印刷可） | ￥717,605 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,442,605 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の市場調査によると、世界の非経口栄養市場規模は、2021年の6,529.10百万ドルから2022年には7,076.38百万ドルへ達し、2027年までにCAGR 8.55%増加して10,686.92百万ドルへ拡大すると予想されています。本調査資料では、非経口栄養の世界市場を調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、栄養種類別（アミノ酸、糖質、電解質、脂質、マルチビタミン製剤・微量元素）分析、剤形別（アンプル、バッグ、ボトル、バイアル）分析、エンドユーザー別（診療所、病院、長期介護事業者）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。本調査資料にはAculife (Nirlife)、Allergan Plc、Amanta Healthcare、Anhui Medipharm Co., Ltd.、B. Braun Melsungen AG、Baxter International, Inc.、Bionova Lifesciences、Claris Lifesciences Ltd.、Fresenius Kabi AG、Grifols International S.A、Guangzhou Green Cross Pharmaceutical Co., Ltd.、Hospira, Inc.、Hubei Shinrezing Pharmaceutical Technology Co., Ltd.、Kuwait Saudi Pharmaceutical Industries Co.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の非経口栄養市場規模：栄養種類別 - アミノ酸の市場規模 - 糖質の市場規模 - 電解質の市場規模 - 脂質の市場規模 - マルチビタミン製剤・微量元素の市場規模 ・世界の非経口栄養市場規模：剤形別 - アンプル型非経口栄養の市場規模 - バッグ型非経口栄養の市場規模 - ボトル型非経口栄養の市場規模 - バイアル型非経口栄養の市場規模 ・世界の非経口栄養市場規模：エンドユーザー別 - 診療所における市場規模 - 病院における市場規模 - 長期介護事業者における市場規模 ・世界の非経口栄養市場規模：地域別 - 南北アメリカの非経口栄養市場規模 アメリカの非経口栄養市場規模 カナダの非経口栄養市場規模 ブラジルの非経口栄養市場規模 ... - アジア太平洋の非経口栄養市場規模 日本の非経口栄養市場規模 中国の非経口栄養市場規模 インドの非経口栄養市場規模 韓国の非経口栄養市場規模 台湾の非経口栄養市場規模 ... - ヨーロッパ/中東/アフリカの非経口栄養市場規模 イギリスの非経口栄養市場規模 ドイツの非経口栄養市場規模 フランスの非経口栄養市場規模 ロシアの非経口栄養市場規模 ... - その他地域の非経口栄養市場規模 ・競争状況 ・企業情報 |
The Global Parenteral Nutrition Market size was estimated at USD 6,529.10 million in 2021 and expected to reach USD 7,076.38 million in 2022, and is projected to grow at a CAGR 8.55% to reach USD 10,686.92 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Parenteral Nutrition to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Nutrient Type, the market was studied across Amino Acids, Carbohydrates, Electrolytes, Lipids, and Multivitamin Formulations & Trace Elements.
Based on Dosage Form, the market was studied across Ampules, Bags, Bottles, and Vials.
Based on End-User, the market was studied across Clinics, Hospitals, and Long-term Care Providers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Parenteral Nutrition market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Parenteral Nutrition Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Parenteral Nutrition Market, including Aculife (Nirlife), Allergan Plc, Amanta Healthcare, Anhui Medipharm Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Bionova Lifesciences, Claris Lifesciences Ltd., Fresenius Kabi AG, Grifols International S.A, Guangzhou Green Cross Pharmaceutical Co., Ltd., Hospira, Inc., Hubei Shinrezing Pharmaceutical Technology Co., Ltd., Kuwait Saudi Pharmaceutical Industries Co., Ori Bionature Sdn Bhd, Otsuka Pharmaceutical Factory, Inc., Pfizer, Inc.(Hospira), Qatar Pharma, Servona GmbH, Shaanxi Iknow Biotechnology Co., Ltd, Sichuan Kelun Pharmaceutical Co. Ltd., SP S.A.R.L, Vifor Pharma, WellPharma Medical Solutions, and Xiamen ShengLang SaiChuang Biological Technology Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Parenteral Nutrition Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Parenteral Nutrition Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Parenteral Nutrition Market?
4. What is the competitive strategic window for opportunities in the Global Parenteral Nutrition Market?
5. What are the technology trends and regulatory frameworks in the Global Parenteral Nutrition Market?
6. What is the market share of the leading vendors in the Global Parenteral Nutrition Market?
7. What modes and strategic moves are considered suitable for entering the Global Parenteral Nutrition Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic diseases such as kidney diseases, liver diseases and cancer
5.1.1.2. Increasing rate of geriatric population and malnourished individuals
5.1.1.3. High natality and premature births around the globe
5.1.2. Restraints
5.1.2.1. Strict government rules regarding the approval of parenteral nutrition
5.1.3. Opportunities
5.1.3.1. Swift towards modernization, over stressed and fast paced lifestyle
5.1.3.2. Technological developments in nutrition
5.1.4. Challenges
5.1.4.1. Lack of knowledge in developing economies
5.2. Cumulative Impact of COVID-19
6. Parenteral Nutrition Market, by Nutrient Type
6.1. Introduction
6.2. Amino Acids
6.3. Carbohydrates
6.4. Electrolytes
6.5. Lipids
6.6. Multivitamin Formulations & Trace Elements
7. Parenteral Nutrition Market, by Dosage Form
7.1. Introduction
7.2. Ampules
7.3. Bags
7.4. Bottles
7.5. Vials
8. Parenteral Nutrition Market, by End-User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
8.4. Long-term Care Providers
9. Americas Parenteral Nutrition Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Parenteral Nutrition Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Parenteral Nutrition Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Aculife (Nirlife)
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Allergan Plc
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Amanta Healthcare
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Anhui Medipharm Co., Ltd.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. B. Braun Melsungen AG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Baxter International, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Bionova Lifesciences
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Claris Lifesciences Ltd.
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Fresenius Kabi AG
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Grifols International S.A
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Guangzhou Green Cross Pharmaceutical Co., Ltd.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Hospira, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Hubei Shinrezing Pharmaceutical Technology Co., Ltd.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Kuwait Saudi Pharmaceutical Industries Co.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Ori Bionature Sdn Bhd
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Otsuka Pharmaceutical Factory, Inc.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Pfizer, Inc.(Hospira)
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Qatar Pharma
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Servona GmbH
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Shaanxi Iknow Biotechnology Co., Ltd
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Sichuan Kelun Pharmaceutical Co. Ltd.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. SP S.A.R.L
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Vifor Pharma
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. WellPharma Medical Solutions
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Xiamen ShengLang SaiChuang Biological Technology Co., Ltd.
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing